fore-8394
forebio therapeutics
['fore8394', 'forebio']
#forebiotherapeutics presents positive interim data from phase 1/2a trial evaluating #fore8394 in patients with advanced #tumors with activating #braf alterations at #esmo22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.